Skip to main content

Advertisement

SpringerLink
Log in

A rare cause of AA amyloidosis and end-stage kidney failure: Answers

  • Clinical Quiz
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Girnius S, Dember L, Doros G, Skinner M (2011) The changing face of AA amyloidosis: a single center experience. Amyloid 18:226–228

    Article  PubMed  Google Scholar 

  2. Bunker D, Gorevic P (2012) AA amyloidosis: Mount Sinai experience, 1997-2012. Mt Sinai J Med 79(6):749–756

    Article  PubMed  Google Scholar 

  3. Ensari C, Ensari A, Tümer N, Ertug E (2005) Clinicopathological and epidemiological analysis of amyloidosis in Turkish patients. Nephrol Dial Transplant 20:1721

    Article  PubMed  Google Scholar 

  4. Real de Asúa D, Costa R, Galván JM, Filigheddu MT, Trujillo D, Cadiñanos J (2014) Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol 6:369–377

    Article  PubMed  PubMed Central  Google Scholar 

  5. Drenth JP, Haagsma CJ, van der Meer JW (1994) Hyperimmunoglobulinemia D and periodic fever syndrome: the clinical spectrum in a series of 50 patients. Medicine 73:133–144

    Article  CAS  PubMed  Google Scholar 

  6. van der Hilst JC, Bodar EJ, Barron KS, Barron KS, Frenkel J, Drenth JP, van der Meer JW, Simon A, International HIDS Study Group (2008) Long-term follow-up, clinical features, and quality of life in a series of 103 patients with hyperimmunoglobulinemia D syndrome. Medicine 87:301–310

    Article  CAS  Google Scholar 

  7. Drenth JPH, Mariman ECM, Van der Velde-Visser SD, Ropers HH, Van der Meer JWM, International Hyper-IgD Study Group (1994) Location of the gene causing hyperimmunoglobulinemia D and periodic fever syndrome differs from that for familial Mediterranean fever. Hum Genet 94:616–620

    Article  CAS  PubMed  Google Scholar 

  8. Ostuni P, Vertolli U, Marson P (1996) Atypical hypergammaglobulinaemia D syndrome with amyloidosis: an overlap with familial Mediterranean fever? Clin Rheumatol 15:610–612

    Article  CAS  PubMed  Google Scholar 

  9. Van der Hilst JC, Simon A, Drenth JP (2005) Hereditary periodic fever and reactive amyloidosis. Clin Exp Med 5:87–98

    Article  Google Scholar 

  10. Drenth JP, Vonk AG, Simon A, Powell R, van der Meer JW (2001) Limited efficacy of thalidomide in the treatment of febrile attacks of the hyper-IgD and periodic fever syndrome: a randomized, double-blind, placebo-controlled trial. J Pharmacol Exp Ther 298:1221–1226

    CAS  PubMed  Google Scholar 

  11. Takadak, Aksentijevich I, Mahadevan V, Dean JA, Kelley RI, Kastner DL (2003) Favorable preliminary experience with etanercept in two patients with the hyperimmunoglobulinemia D and periodic fever syndrome. Arthritis Rheum 48(9):2645–2651

    Article  CAS  Google Scholar 

  12. Marchetti F, Barbi E, Tommasini A, Oretti C, Ventura A (2004) Inefficacy of etanercept in a child with hyper-IgD syndrome and periodic fever. Clin Exp Rheumatol 22(6):791–792

    CAS  PubMed  Google Scholar 

  13. Ayar Y, Ersoy A, Oksuz MF, Ocakoglu G, Vuruskan BA, Yildiz A, Isiktas E, Oruc A, Celikci S, Arslan I, Sahin AB, Güllülü M (2017) Clinical outcomes and survival in AA amyloidosis patients. Rev Bras Reumatol Engl Ed 57:535–544. https://doi.org/10.1016/j.rbre.2017.02.002

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Nephrology, Department of Pediatrics, Koç University School of Medicine, Davutpaşa cad no: 4 Topkapı, 34010, Istanbul, Turkey

    Mehmet Taşdemir & Ilmay Bilge

  2. Koç University School of Medicine, Istanbul, Turkey

    Sezen Yılmaz

  3. Department of Pathology, Acıbadem Maslak Hospital, Istanbul, Turkey

    Zeliha Füsun Baba

Authors
  1. Mehmet Taşdemir
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sezen Yılmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Zeliha Füsun Baba
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ilmay Bilge
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mehmet Taşdemir.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Statement of honorarium, grant, or other form of payment to another person for manuscript preparation

The authors stated that the manuscript is of their original work and no one except the authors included into preparation of the manuscript.

Additional information

This article refers to the article that can be found at https://doi.org/10.1007/s00467-018-4152-7.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Taşdemir, M., Yılmaz, S., Baba, Z.F. et al. A rare cause of AA amyloidosis and end-stage kidney failure: Answers. Pediatr Nephrol 34, 1537–1539 (2019). https://doi.org/10.1007/s00467-018-4153-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-018-4153-6

Keywords

Search

Navigation